Hermans, Sabine M <br/><br/>
Risk of tuberculosis after antiretroviral treatment initiation: a comparison between efavirenz and nevirapine using inverse probability weighting.  [electronic resource] 

 -  Antiviral therapy  2013 
 - 615-22 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2040-2058 
<br/><br/><label>Standard No.: </label>10.3851/IMP2525  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Alkynes<br/>Anti-HIV Agents--adverse effects<br/>Antiretroviral Therapy, Highly Active<br/>Benzoxazines--adverse effects<br/>CD4 Lymphocyte Count<br/>CD4-Positive T-Lymphocytes--drug effects<br/>Cohort Studies<br/>Comorbidity<br/>Cyclopropanes<br/>Female<br/>HIV Infections--drug therapy<br/>HIV-1--drug effects<br/>Humans<br/>Male<br/>Middle Aged<br/>Mycobacterium tuberculosis--immunology<br/>Nevirapine--adverse effects<br/>Proportional Hazards Models<br/>Risk Factors<br/>Survival Analysis<br/>Tuberculosis, Pulmonary--etiology<br/>Uganda--epidemiology<br/>Viral Load--drug effects